Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Bamlanivimab Emergency use authorization Experimental Antiviral Jan/25/2022 4 12
Remdesivir Approved by FDA Experimental Antiviral Jan/21/2022 69 5
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Jul/12/2021 87 22
Chloroquine phosphate Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/27/2021 25 9
Baicalin Potential treatment - pre-clinical evidence Natural product Antiviral Apr/22/2021 5 0
Teniposide Potential treatment - theoretical effect Experimental Antiviral Apr/12/2021 3 0
Glycyrrhizic acid Potential treatment - pre-clinical evidence Natural product Antiviral Apr/02/2021 5 0
Cyclosporine Potential treatment - clinical evidence Used to treat other disease Other treatment Mar/23/2021 7 0
Berberine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/22/2021 3 0
Doxycycline Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/14/2021 6 0